Tamara Illescas
Delta Air Lines
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Tamara Illescas.
Ultrasound in Obstetrics & Gynecology | 2012
Pilar Martinez-Ten; Begoña Adiego; Tamara Illescas; C. Bermejo; A. E. Wong; Waldo Sepulveda
To determine whether systematic examination of primary and secondary palates using three‐dimensional (3D) ultrasound aids in the identification of orofacial clefts in the first trimester.
Prenatal Diagnosis | 2012
Begoña Adiego; Tamara Illescas; Pilar Martinez-Ten; C. Bermejo; Javier Perez-Pedregosa; Amy E. Wong; Waldo Sepulveda
This paper aimed to determine the feasibility of identification and measurement reproducibility of intracranial translucency (IT) in our population.
Ultrasound in Obstetrics & Gynecology | 2014
C. Bermejo; Pilar Martinez-Ten; M. Recio; L. Ruiz-López; D. Díaz; Tamara Illescas
To investigate the accuracy of three‐dimensional ultrasound (3D‐US) with respect to magnetic resonance imaging (MRI), and compared to clinical examination, in the assessment of cervix and vagina in women with uterine malformations.
Journal of Ultrasound in Medicine | 2011
Begoña Adiego; Pilar Martinez-Ten; Javier Perez-Pedregosa; Tamara Illescas; Esther Barron; Amy E. Wong; Waldo Sepulveda
The purpose of this study was to assess the diagnostic accuracy and infant outcomes of antenatally detected renal duplex anomalies.
Journal of Ultrasound in Medicine | 2010
Pilar Martinez-Ten; Begoña Adiego; Javier Perez-Pedregosa; Tamara Illescas; Amy E. Wong; Waldo Sepulveda
Objective. The purpose of this study was to evaluate a new sonographic technique for identifying the nasal bones using the retronasal triangle view, ie, the coronal plane at which the palate and frontal processes of the maxilla are simultaneously visualized. Methods. Three‐dimensional (3D) volumes were acquired from women undergoing first‐trimester sonographic screening for aneuploidy by 2 accredited operators. Those data sets in which the fetal face was clearly identified were selected for offline analysis by 2 other observers who were unaware of the sonographic or clinical findings. The nasal bones were classified as both present, only 1 present (right or left), or absent according to the presence or absence of 2 small paired echogenic linear structures at the upper tip of the retronasal triangle as determined by 3D navigation in the coronal plane and compared to those findings obtained by 3D navigation in the sagittal plane. Additional 3D data sets involving a subset of 4 first‐trimester fetuses with trisomy 21 and absent nasal bones were also analyzed retrospectively and included randomly in the study group. Results. A total of 110 3D data sets were analyzed, of which 86% were obtained transabdominally and 14% transvaginally. The quality of nasal bone identification was classified subjectively by the observers as good in 67% of cases, fair in 29%, and poor in 4%. The nasal bones were classified as at least 1 present in 106 of the cases (96%) and absent in 4 (4%), with complete agreement between observers in both the sagittal and coronal planes (κ = 1). Discrimination between the right and left nasal bones was possible in 89% and 93% for observer A and in 96% and 96% for observer B by assessing the sagittal and coronal views, respectively (right nasal bone: κ = 0.90 [95% confidence interval (CI), 0.79–1]; left nasal bone: κ = 0.85 [95% CI, 0.60–0.99]). The nasal bones were not identified at the level of the retronasal triangle view in any of the fetuses with trisomy 21 and absent nasal bones. Conclusions. This study shows that the nasal bones can be confidently identified as paired echogenic structures located at the upper tip of the retronasal triangle. This coronal view of the fetal face offers the possibility of screening for the presence or absence of the nasal bones in the first trimester, especially when the standard midsagittal views of the fetal face are suboptimal because of fetal or maternal factors. Because both nasal bones can be evaluated simultaneously in the coronal plane, the retronasal triangle view may be advantageous over the conventional midsagittal view assessment, in which only 1 of the 2 nasal bones is evaluated.
Ultrasound in Obstetrics & Gynecology | 2016
E. Carreras; A. Maroto; Tamara Illescas; Mar Meléndez; Silvia Arévalo; Jose L. Peiró; C.G. García‐Fontecha; M. Belfort; A. Cuxart
To report our preliminary experience in the use of prenatal ultrasound examination to assess lower‐limb movements in fetuses with myelomeningocele. We aimed to determine the accuracy of this method to establish the segmental level of neurological lesion, as this is the best known predictor of the future ability to walk.
Ultrasound in Obstetrics & Gynecology | 2015
E. Carreras; A. Maroto; Tamara Illescas; Mar Meléndez; Silvia Arévalo; Jose L. Peiró; C.G. García‐Fontecha; M. Belfort; A. Cuxart
To report our preliminary experience in the use of prenatal ultrasound examination to assess lower‐limb movements in fetuses with myelomeningocele. We aimed to determine the accuracy of this method to establish the segmental level of neurological lesion, as this is the best known predictor of the future ability to walk.
European Journal of Obstetrics & Gynecology and Reproductive Biology | 2013
Tamara Illescas; Cristina Mata Fernández; Dolores Ortega; Miriam de la Puente; Pluvio J. Coronado; Joaquín Montalvo
OBJECTIVES Combined screening for chromosome abnormalities in the first trimester of pregnancy is based on maternal age, nuchal translucency (NT) and biochemical markers (PAPP-A and free β-hCG). We sought to assess the value of the variables used in the combined screening strategy taking into account maternal gravidity and foetal gender. STUDY DESIGN Between July 1999 and December 2009, a total of 21,193 singleton pregnancies were screened for aneuploidy in the first trimester, in the Hospital Clínico San Carlos (Madrid, Spain). In the original database foetal gender data were available in 4370 euploid cases, and there were 2343 women with at least two consecutive pregnancies. We conducted a retrospective assessment of ultrasound and biochemical markers taking into account foetal gender and maternal gravidity, and evaluated the effect on the performance of screening, in terms of detection rates and false positive rates. Information on pregnancy outcome was obtained from the hospitals intranet medical records or by contacting the patient by telephone postpartum. Karyotype was ascertained by amniocentesis or chorionic villus sampling, and euploid status was assumed in newborns with normal phenotype. Students t-tests (paired or unpaired as appropriate) were applied to the data, and the Bland-Altmann method was applied in evaluating individual differences in markers between successive gestations. RESULTS PAPP-A decreased significantly between the first and the second pregnancy (p<0.01). PAPP-A and free β-hCG values were significantly higher (p=0.04 and p<0.01 respectively) and NT was lower (p=0.02) in pregnancies with a female foetus. CONCLUSIONS Correlations between the biochemical variables in relation to gravidity and foetal gender can introduce a bias in the calculated risk of chromosome abnormalities. Differences in NT measurements with respect to foetal gender do not seem to be of clinical importance. NT is independent of gravidity so routine use of NT compensates for the influence of these maternal-foetal variables on the values of biochemical parameters. Hence, the bias in overall combined screening is small.
Journal of Perinatal Medicine | 2016
Giovanni Monni; Tamara Illescas; Ambra Iuculano; Marcella Floris; Federica Mulas; Laurence B. McCullough; Frank A. Chervenak; Shari E. Gelber
Abstract Objective: This paper describes the 20-year experience with selective feticide (SF) of high-order multiple quadruplet and higher pregnancies in a single center. Methods: The paper describes protocols, procedures, management, outcomes, and ethical issues. Results: SF was performed in 49 pregnancies with 244 fetuses, with median gestational age of 12+2 weeks. The initial number was nine (one case), eight (one case), seven (three cases), six (11 cases), five (eight cases), and four (27 cases). Nuchal translucency was utilized prior to the procedure starting in 1996. The technique was transabdominal ultrasound-guided and intrathoracic injection of potassium chloride. One pregnancy (with seven fetuses) was reduced to three, 42 to two, and four (starting with four fetuses) to singletons. There were ten pregnancy losses (20.4%). A decreasing trend in losses was evident over the 20-year time period: 7/23 (30.4%) from 1994 to 2004 down to 3/26 (11.5%) for 2004–2014. No chromosomal abnormalities were present in any of the survivors. The ethical issues focus on the justification of SF in high-order multifetal pregnancies. Conclusion: In this series, pregnancy loss decreased with operator experience. Excellent outcomes can be achieved with the ethically justified use of feticide in high-order multiple pregnancies.
Ultrasound in Obstetrics & Gynecology | 2018
Pilar Martinez-Ten; Tamara Illescas; Begoña Adiego; M. Estévez; C. Bermejo; A. E. Wong; Waldo Sepulveda
To assess non‐visualization of the choroid plexus of the fourth ventricle (CP‐4V) as a simple, qualitative and reproducible first‐trimester ultrasound feature of the posterior fossa for the prediction of central nervous system (CNS) anomalies and chromosomal defects.